AKT1 and lung cancer: Eriodictyol could inhibit the growth of lung cancer cell lines through induction of mitochondrial-mediated apoptosis, G2/M cell cycle arrest, and inhibition of mTOR/PI3K/Akt cascade signaling pathway [25].